{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:55:58Z","timestamp":1781654158698,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Peking University Medicine Fund of Fostering Young Scholars\u2019 Scientific & Technological Innovation","award":["BMU2024YFJHPY023"],"award-info":[{"award-number":["BMU2024YFJHPY023"]}]},{"name":"Peking University People\u2019s Hospital Scientific Research Development Funds","award":["RDJP2022-57, RDX2023-13"],"award-info":[{"award-number":["RDJP2022-57, RDX2023-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-026-01791-4","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:36:47Z","timestamp":1777441007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a novel LC-MS\/MS method for concurrent determination of imipenem, relebactam, and cilastatin in human serum, urine and peritoneal drainage fluid"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaoyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"crossref","unstructured":"EClinicalMedicine. Antimicrobial resistance: a top ten global public health threat. eClinicalMedicine. 2021;41.","DOI":"10.1016\/j.eclinm.2021.101221"},{"key":"1791_CR2","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1128\/AAC.00565-10","volume":"54","author":"D Marchaim","year":"2010","unstructured":"Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 2010;54:5099\u2013104.","journal-title":"Antimicrob Agents Chemother"},{"key":"1791_CR3","doi-asserted-by":"publisher","first-page":"e01411","DOI":"10.1128\/AAC.01411-17","volume":"62","author":"ML Rizk","year":"2018","unstructured":"Rizk ML, Rhee EG, Jumes PA, Gotfried MH, Zhao T, Mangin E, et al. Intrapulmonary Pharmacokinetics of Relebactam, a Novel \u03b2-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects. Antimicrob Agents Chemother. 2018;62:e01411\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"1791_CR4","first-page":"e00280","volume":"62","author":"EG Rhee","year":"2018","unstructured":"Rhee EG, Rizk ML, Calder N, Nefliu M, Warrington SJ, Schwartz MS, et al. Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a \u03b2-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants. Antimicrob Agents Chemother. 2018;62:e00280\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1358\/dot.2020.56.4.3075796","volume":"56","author":"R Thakare","year":"2020","unstructured":"Thakare R, Dasgupta A, Chopra S. Imipenem\/cilastatin sodium\/relebactam fixed combination to treat urinary infections and complicated intra-abdominal bacterial infections. Drugs Today (Barc). 2020;56:241\u201355.","journal-title":"Drugs Today (Barc)"},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","volume":"78","author":"GG Zhanel","year":"2018","unstructured":"Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, et al. Imipenem\u2013Relebactam and Meropenem\u2013Vaborbactam: Two Novel Carbapenem-\u03b2-Lactamase Inhibitor Combinations. Drugs. 2018;78:65\u201398.","journal-title":"Drugs"},{"key":"1791_CR7","doi-asserted-by":"publisher","first-page":"e00573","DOI":"10.1128\/AAC.00573-18","volume":"62","author":"A Gomez-Simmonds","year":"2018","unstructured":"Gomez-Simmonds A, Stump S, Giddins MJ, Annavajhala MK, Uhlemann A-C. Clonal Background, Resistance Gene Profile, and Porin Gene Mutations Modulate In Vitro Susceptibility to Imipenem-Relebactam in Diverse Enterobacteriaceae. Antimicrob Agents Chemother. 2018;62:e00573\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"1791_CR8","doi-asserted-by":"publisher","first-page":"e02406","DOI":"10.1128\/AAC.02406-17","volume":"62","author":"MD Barnes","year":"2018","unstructured":"Barnes MD, Bethel CR, Alsop J, Becka SA, Rutter JD, Papp-Wallace KM, et al. Inactivation of the Pseudomonas-Derived Cephalosporinase-3 (PDC-3) by Relebactam. Antimicrob Agents Chemother. 2018;62:e02406\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"1791_CR9","doi-asserted-by":"crossref","unstructured":"Li J, Wei F, Xiang P, Tang Z, Ding L, Chen LF et al. A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem\/cilastatin\/relebactam (IMI\/REL) vs piperacillin\/tazobactam (PIP\/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP). Int J Infect Dis. 2025;153.","DOI":"10.1016\/j.ijid.2024.107357"},{"key":"1791_CR10","doi-asserted-by":"publisher","first-page":"e4539","DOI":"10.1093\/cid\/ciaa803","volume":"73","author":"I Titov","year":"2020","unstructured":"Titov I, Wunderink RG, Roquilly A, Rodr\u00edguez Gonzalez D, David-Wang A, Boucher HW, et al. A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem\/Cilastatin\/Relebactam Versus Piperacillin\/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study). Clin Infect Dis. 2020;73:e4539\u201348.","journal-title":"Clin Infect Dis"},{"key":"1791_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4155\/bio.11.51","volume":"3","author":"W Jian","year":"2011","unstructured":"Jian W, Xu Y, Edom RW, Weng N. Analysis of polar metabolites by hydrophilic interaction chromatography\u2013MS\/MS. Bioanalysis. 2011;3:899\u2013912.","journal-title":"Bioanalysis"},{"key":"1791_CR12","unstructured":"Team C. Chinese Pharmacopoeia 9012 Guidelines for Validation of Quantitative Analytical Method of Biological Samples."},{"key":"1791_CR13","unstructured":"ICH M10. Bioanalytical Method Validation and Study Sample Analysis."},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"124699","DOI":"10.1016\/j.jchromb.2025.124699","volume":"1263","author":"Z Qi","year":"2025","unstructured":"Qi Z, Zhang S, Li J, Qian S, Song D, Ye X. LC-MS\/MS analysis of five antibiotics in dried blood spots for therapeutic drug monitoring of ICU patients. J Chromatogr B. 2025;1263:124699.","journal-title":"J Chromatogr B"},{"key":"1791_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/jms.3240","volume":"48","author":"Z-Y Hu","year":"2013","unstructured":"Hu Z-Y, Boucher BA, Laizure SC, Herring VL, Parker RB, Hickerson WL. Nonvolatile salt-free stabilizer for the quantification of polar imipenem and cilastatin in human plasma using hydrophilic interaction chromatography\/quadrupole mass spectrometry with contamination sensitive off-axis electrospray. J Mass Spectrom. 2013;48:945\u201350.","journal-title":"J Mass Spectrom"},{"key":"1791_CR16","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/molecules27030926","volume":"27","author":"R W\u0142odarski","year":"2022","unstructured":"W\u0142odarski R, \u017buchowska K, Filipiak W. Quantitative Determination of Unbound Piperacillin and Imipenem in Biological Material from Critically Ill Using Thin-Film Microextraction-Liquid Chromatography-Mass Spectrometry. Molecules. 2022;27:926.","journal-title":"Molecules"},{"key":"1791_CR17","doi-asserted-by":"publisher","first-page":"104625","DOI":"10.1016\/j.idnow.2022.09.020","volume":"53","author":"M Lafaurie","year":"2023","unstructured":"Lafaurie M, Burdet C, Hammas K, Goldwirt L, Ber\u00e7ot B, Sauvageon H, et al. Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients. Infect Dis Now. 2023;53:104625.","journal-title":"Infect Dis Now"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-026-01791-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:33:01Z","timestamp":1781652781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13065-026-01791-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1186\/s13065-026-01791-4","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the Declaration of Helsinki, and approved by the Ethical Review Committee of Peking University People\u2019s Hospital (2024PHB316-001). Informed consent was achieved from all individuals included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}